Signal Transduction Inhibitors, Hibarimicins, A, B, C, D and G Produced by Microbispora. I. Taxonomy, Fermentation, Isolation and Physico-chemical and Biological Properties
Overview
Pharmacology
Affiliations
Strain TP-AO121 which produces a complex of novel tyrosine kinase inhibitors designated hibarimicins A, B, C, D and G was considered to be a new subspecies of Microbispora rosea, and the name, Microbispora rosea subsp. hibaria, was proposed. Hibarimicins A, B, C and D specifically inhibited the src tyrosine kinase activity without affecting protein kinase A or protein kinase C. They also showed in vitro anti-Gram-positive bacterial and antitumor activities. The molecular formulae of hibarimicins A, B, C, D and G were assigned to be C85H112O37, C85H112O37, C83H110O36, C85H112O38, and C85H112O39 respectively.
Li K, Guo Z, Bai L Synth Syst Biotechnol. 2024; 9(4):701-712.
PMID: 38868608 PMC: 11167396. DOI: 10.1016/j.synbio.2024.05.012.
Synthetic studies directed toward the AB decalin common to HMP-Y1 and hibarimicinone.
Hempel J, Engers D, Sulikowski G Tetrahedron Lett. 2020; 55(13):2157-2159.
PMID: 32855575 PMC: 7449242. DOI: 10.1016/j.tetlet.2014.02.069.
Ashu E, Xu J, Yuan Z J Cancer. 2019; 10(8):1781-1793.
PMID: 31205534 PMC: 6547982. DOI: 10.7150/jca.31699.
Studies on a biomimetic oxidative dimerization approach to the hibarimicins.
Romaine I, Sulikowski G Tetrahedron Lett. 2015; 56(23):3617-3619.
PMID: 26236055 PMC: 4518470. DOI: 10.1016/j.tetlet.2015.01.127.
A comprehensive review of glycosylated bacterial natural products.
Elshahawi S, Shaaban K, Kharel M, Thorson J Chem Soc Rev. 2015; 44(21):7591-697.
PMID: 25735878 PMC: 4560691. DOI: 10.1039/c4cs00426d.